DE60033555D1 - Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden - Google Patents
Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptidenInfo
- Publication number
- DE60033555D1 DE60033555D1 DE60033555T DE60033555T DE60033555D1 DE 60033555 D1 DE60033555 D1 DE 60033555D1 DE 60033555 T DE60033555 T DE 60033555T DE 60033555 T DE60033555 T DE 60033555T DE 60033555 D1 DE60033555 D1 DE 60033555D1
- Authority
- DE
- Germany
- Prior art keywords
- breast cancer
- compositions
- detecting
- provides
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16567399P | 1999-11-16 | 1999-11-16 | |
US165673P | 1999-11-16 | ||
US17217099P | 1999-12-17 | 1999-12-17 | |
US172170P | 1999-12-17 | ||
US17886000P | 2000-01-27 | 2000-01-27 | |
US178860P | 2000-01-27 | ||
US20172100P | 2000-05-03 | 2000-05-03 | |
US201721P | 2000-05-03 | ||
US709947P | 2000-11-10 | ||
US09/709,947 US6936424B1 (en) | 1999-11-16 | 2000-11-10 | Materials and methods for detection and treatment of breast cancer |
PCT/US2000/031483 WO2001036470A2 (en) | 1999-11-16 | 2000-11-16 | Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60033555D1 true DE60033555D1 (de) | 2007-04-05 |
DE60033555T2 DE60033555T2 (de) | 2007-11-29 |
Family
ID=30449666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60033555T Expired - Fee Related DE60033555T2 (de) | 1999-11-16 | 2000-11-16 | Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden |
Country Status (9)
Country | Link |
---|---|
US (2) | US6936424B1 (de) |
EP (2) | EP1232177B1 (de) |
JP (2) | JP2003528296A (de) |
AT (1) | ATE354588T1 (de) |
AU (2) | AU1658901A (de) |
CA (2) | CA2390607A1 (de) |
DE (1) | DE60033555T2 (de) |
ES (1) | ES2282149T3 (de) |
WO (2) | WO2001036470A2 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936424B1 (en) | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
AUPQ886100A0 (en) * | 2000-07-19 | 2000-08-10 | Biotron Limited | Diagnostic test |
CA2320549A1 (en) * | 2000-09-25 | 2002-03-25 | Eastern Virginia Medical College | Biomarkers of transitional cell carcinoma of the bladder |
CA2457437A1 (en) * | 2001-08-03 | 2003-02-20 | Biotron Limited | A novel cancer marker and uses therefor in the diagnosis of cancer |
US6756586B2 (en) | 2001-10-15 | 2004-06-29 | Vanderbilt University | Methods and apparatus for analyzing biological samples by mass spectrometry |
WO2003054549A2 (en) * | 2001-12-08 | 2003-07-03 | Micromass Uk Limited | Method of mass spectrometry |
DE10296200D2 (de) * | 2001-12-21 | 2004-11-04 | Biovision Ag | Verfahren zur Diagnose von Brustkrebserkrankungen, zugehörige Peptide und deren Verwendungen |
US20050170352A1 (en) * | 2002-03-06 | 2005-08-04 | Johns Hopkins University | Use of biomarkers to detect breast cancer |
AU2002950878A0 (en) * | 2002-08-20 | 2002-09-12 | Proteome Systems Intellectual Property Pty Ltd | Method for diagnosing disorders |
CN100437115C (zh) | 2002-12-20 | 2008-11-26 | 霍夫曼-拉罗奇有限公司 | 烟酰胺n-甲基转移酶作为结肠直肠癌标志的用途 |
WO2004090550A2 (en) * | 2003-04-08 | 2004-10-21 | Colotech A/S | A method for detection of colorectal cancer in human samples |
US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050112622A1 (en) * | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
US20050037331A1 (en) * | 2003-08-13 | 2005-02-17 | William Galbraith | Apparatuses and methods for reducing albumin in samples |
GB0320648D0 (en) * | 2003-09-03 | 2003-10-01 | Randox Lab Ltd | Molecular marker |
US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
US20060068434A1 (en) * | 2004-09-21 | 2006-03-30 | Jay Stoerker | Methods and compositions for detecting cancer using components of the U2 spliceosomal particle |
JP2008535771A (ja) * | 2004-12-14 | 2008-09-04 | アプレラ コーポレイション | カチオン性リポソームおよびその使用方法 |
ATE501267T1 (de) | 2005-01-06 | 2011-03-15 | Eastern Virginia Med School | Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs |
JP5200246B2 (ja) * | 2005-03-14 | 2013-06-05 | 財団法人ヒューマンサイエンス振興財団 | 膵臓癌診断用マーカータンパク質 |
US7749445B2 (en) | 2005-05-02 | 2010-07-06 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
US7648844B2 (en) | 2005-05-02 | 2010-01-19 | Bioscale, Inc. | Method and apparatus for detection of analyte using an acoustic device |
US20100173788A1 (en) * | 2005-06-21 | 2010-07-08 | Vermillion, Inc. | Biomarkers for breast cancer |
WO2007035766A2 (en) * | 2005-09-19 | 2007-03-29 | The Johns Hopkins University | Biomarker for prostate cancer |
EP1941280A2 (de) * | 2005-10-13 | 2008-07-09 | Applera Corporation | Verfahren zur entwicklung eines biomolekültests |
WO2008039482A2 (en) * | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
US8354280B2 (en) | 2007-09-06 | 2013-01-15 | Bioscale, Inc. | Reusable detection surfaces and methods of using same |
US20090170132A1 (en) * | 2007-12-11 | 2009-07-02 | Pevsner Paul H | Methods for detecting colon carcinoma |
US8232073B2 (en) | 2009-01-02 | 2012-07-31 | Zacharon Pharmaceuticals, Inc. | Quantification of non-reducing end glycan residual compounds |
US9029530B2 (en) * | 2009-01-02 | 2015-05-12 | Biomarin Pharmaceutical Inc. | Detection of oligosaccharides |
US8809009B2 (en) | 2009-01-02 | 2014-08-19 | Biomarin Pharmaceutical Inc. | Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
WO2011021386A1 (en) * | 2009-08-21 | 2011-02-24 | Oncotherapy Science, Inc. | Cstf2 for target genes of lung cancer therapy and diagnosis |
WO2012167163A2 (en) * | 2011-06-03 | 2012-12-06 | University Of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
EP3256040A4 (de) * | 2015-02-11 | 2018-08-08 | Abbott Diabetes Care Inc. | Verfahren, vorrichtungen und systeme zur unterscheidung von kanzerösem und nichtkanzerösem gewebe |
EP3387430A4 (de) * | 2015-12-11 | 2019-08-14 | Expression Pathology, Inc. | Srm/mrm-tests |
JP7278220B2 (ja) * | 2017-04-28 | 2023-05-19 | マシモ・コーポレイション | スポットチェック測定システム |
CN107677825B (zh) * | 2017-10-06 | 2019-04-23 | 汉氏联合(天津)干细胞研究院有限公司 | 一种用于宫颈癌诊断的肿瘤诊断组合物和用于制备诊断试剂盒的用途 |
EP4010456A4 (de) | 2019-08-05 | 2023-09-13 | Seer, Inc. | Systeme und verfahren zur probenvorbereitung, datenerzeugung und proteinkoronaanalyse |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264550A (en) | 1985-04-15 | 1993-11-23 | Scios Nova Inc. | Human anti-inflammatory phospholipase inhibitor protein |
US5561222A (en) | 1989-11-15 | 1996-10-01 | Duke University | RNA-binding proteins useful for the control of cellular genetic processing and expression |
EP0460607A3 (en) | 1990-06-05 | 1992-04-01 | Bristol-Myers Squibb Company | Novel monoclonal antibody to novel antigen associated with human tumors |
US5792664A (en) | 1992-05-29 | 1998-08-11 | The Rockefeller University | Methods for producing and analyzing biopolymer ladders |
CA2512290C (en) | 1993-05-28 | 2010-02-02 | Baylor College Of Medicine | Method and apparatus for desorption and ionization of analytes |
WO1996029408A1 (en) | 1995-03-23 | 1996-09-26 | Immunex Corporation | Il-17 receptor |
WO1997002361A1 (en) | 1995-07-03 | 1997-01-23 | Akzo Nobel N.V. | A method for determining the integrity of nucleic acid |
US5962242A (en) | 1995-09-19 | 1999-10-05 | Immuna Care Corporation | Methods of predicting estrogen-dependent osteopenia |
DE19632521A1 (de) | 1996-08-13 | 1998-02-19 | Forssmann Wolf Georg | Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern |
EP0922226B2 (de) | 1996-08-13 | 2008-06-25 | Digilab, Inc. | Verfahren zur erfassung des status eines organismus durch messung von peptiden |
US5798266A (en) | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
US7008778B1 (en) * | 1997-02-03 | 2006-03-07 | Human Genome Sciences, Inc. | Breast cancer specific gene 1 |
JP2001523096A (ja) | 1997-03-21 | 2001-11-20 | エム ユー エス シー ファンデーション フォーリサーチ ディベロップメント | 乳癌の診断および治療のための方法ならびに組成物 |
NZ516848A (en) | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
US6410692B2 (en) | 1998-02-02 | 2002-06-25 | Novadx, Inc. | Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix |
AU6261998A (en) | 1998-02-02 | 1999-08-16 | Novadx | Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix |
US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
US6753314B1 (en) * | 1999-04-01 | 2004-06-22 | Curagen Corporation | Protein-protein complexes and methods of using same |
US6936424B1 (en) | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
US20060068434A1 (en) * | 2004-09-21 | 2006-03-30 | Jay Stoerker | Methods and compositions for detecting cancer using components of the U2 spliceosomal particle |
-
2000
- 2000-11-10 US US09/709,947 patent/US6936424B1/en not_active Expired - Fee Related
- 2000-11-16 CA CA002390607A patent/CA2390607A1/en not_active Abandoned
- 2000-11-16 EP EP00979182A patent/EP1232177B1/de not_active Expired - Lifetime
- 2000-11-16 WO PCT/US2000/031483 patent/WO2001036470A2/en active IP Right Grant
- 2000-11-16 EP EP00978722A patent/EP1240521A2/de not_active Withdrawn
- 2000-11-16 JP JP2001538814A patent/JP2003528296A/ja not_active Withdrawn
- 2000-11-16 AU AU16589/01A patent/AU1658901A/en not_active Abandoned
- 2000-11-16 DE DE60033555T patent/DE60033555T2/de not_active Expired - Fee Related
- 2000-11-16 ES ES00979182T patent/ES2282149T3/es not_active Expired - Lifetime
- 2000-11-16 AT AT00979182T patent/ATE354588T1/de not_active IP Right Cessation
- 2000-11-16 CA CA002391212A patent/CA2391212A1/en not_active Abandoned
- 2000-11-16 WO PCT/US2000/031492 patent/WO2001036977A2/en not_active Application Discontinuation
- 2000-11-16 AU AU16152/01A patent/AU1615201A/en not_active Abandoned
- 2000-11-16 JP JP2001538959A patent/JP2004500056A/ja active Pending
-
2005
- 2005-07-29 US US11/194,051 patent/US20060160154A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2391212A1 (en) | 2001-05-25 |
WO2001036977A8 (en) | 2002-01-24 |
JP2003528296A (ja) | 2003-09-24 |
DE60033555T2 (de) | 2007-11-29 |
WO2001036977A2 (en) | 2001-05-25 |
CA2390607A1 (en) | 2001-05-25 |
US6936424B1 (en) | 2005-08-30 |
ATE354588T1 (de) | 2007-03-15 |
EP1232177B1 (de) | 2007-02-21 |
WO2001036470A3 (en) | 2002-01-24 |
JP2004500056A (ja) | 2004-01-08 |
EP1240521A2 (de) | 2002-09-18 |
WO2001036470A2 (en) | 2001-05-25 |
WO2001036977A3 (en) | 2001-11-22 |
EP1232177A2 (de) | 2002-08-21 |
ES2282149T3 (es) | 2007-10-16 |
US20060160154A1 (en) | 2006-07-20 |
AU1615201A (en) | 2001-05-30 |
AU1658901A (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60033555D1 (de) | Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden | |
ATE332505T1 (de) | Verfahren und zusammensetzung zur auffindung von cervix-krebs | |
ATE437369T1 (de) | Enzymkatalysierte metalldeposition zum verstärkten in-situ-nachweis von immunhistologischen epitopen und nukleinsäuresequenzen | |
ATE223727T1 (de) | Erkennung und modulierung von iaps und naip zur diagnose und behandlung von proliferativen erkrankungen | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
ATE431853T1 (de) | Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes | |
DE69942451D1 (de) | Methode zum schnellen identifizieren von kleinen organischen liganden | |
DK0757723T3 (da) | Genetiske ændringer, der korrelerer med lungecarcinoma | |
KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도 | |
ATE364089T1 (de) | Reagenzien und methoden zum nachweis von erkrankungen der brust | |
WO1995016919A3 (en) | Methods and compositions for the detection of colon cancers | |
WO2006034278A3 (en) | Methods and compositions for detecting cancer using components of the u2 spliceosomal particle | |
DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
ATE487792T1 (de) | Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen | |
FI973561A (fi) | Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remanenssimittausten avulla ja mainittujen yhdisteiden käyttö | |
ATE233405T1 (de) | Verfahren zur detektierung eines biologischen materials, eingangphase, detektionsphase und diese enthaltende reagenz | |
DE60010323D1 (de) | Fluoreszenzkorrelationsspektroskopie zur identifizierung von verbindung-ziel-bindung | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
WO2002078636A3 (en) | Detection and treatment of colorectal cancer | |
WO2002075314A8 (en) | Detection and treatment of prostate cancer | |
ATE353544T1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
SE0201392D0 (sv) | Fusion polypeptide, use thereof and methods employing it | |
DE60216482D1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
ATE410691T1 (de) | Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome | |
ATE124537T1 (de) | Verfahren zum nachweis der zellularer pathologie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MATRITECH, INC. (N.D.GES.D. STAATES DELAWARE),, US |
|
8339 | Ceased/non-payment of the annual fee |